GlassScriptPhysician profile
Ravindra Kashyap
NPI 1437145273
$5,482.53
in general payments reported to CMS, 2019-2025
32 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $220 · 2021: $299 · 2022: $456 · 2023: $1,252 · 2024: $911 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,734 · Education: $259 · Travel and Lodging: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,734.20 |
| Education | $259.20 |
| Travel and Lodging | $173.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,144.58 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $605.68 | 2019-2025 | Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $521.16 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $493.59 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Harmony Biosciences LLC | $421.69 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $385.75 | 2019-2025 | |
| Mylan Specialty L.P. | $228.55 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $184.26 | 2019-2022 | |
| Genzyme Corporation | $171.24 | 2019-2025 | |
| Amgen INC. | $140.74 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $140.22 | 2019-2024 | Prolastin-C Liquid |
| Insmed, INC. | $131.25 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $102.42 | 2019-2024 | (Ak6) Vest Therapy |
| Bayer Healthcare Pharmaceuticals INC. | $94.74 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.26 | 2022-2024 | Glassia |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $81.23 | 2023-2025 | Smartvest |
| Viatris Specialty LLC | $80.21 | 2025 | Yupelri |
| Genentech USA, INC. | $60.39 | 2019-2020 | |
| Shire North American Group INC | $54.75 | 2019 | |
| Intuitive Surgical, INC. | $50.91 | 2023 | Da Vinci Surgical System |
| Axsome Therapeutics, INC. | $48.16 | 2025 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $47.26 | 2021-2022 | |
| Inspire Medical Systems, INC. | $41.25 | 2023-2024 | Inspire |
| Alexion Pharmaceuticals, INC. | $30.59 | 2024 | Ultomiris |
| La Jolla Pharmaceutical Company | $23.97 | 2023 | Giapreza |
| Verona Pharma, INC. | $19.34 | 2025 | Ohtuvayre |
| Shionogi INC | $19.28 | 2024 | Fetroja |
| Pulmonx Corporation | $18.06 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.66 | 2019 | |
| Inogen, INC. | $14.82 | 2022 | |
| Vanda Pharmaceuticals INC. | $14.76 | 2021 | |
| Circassia INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravindra Kashyap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.